Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | PRKDC | P78527 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22044949 | 0.97 | ALOX5 (0.36) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL22045386 | 0.94 | ALOX5 (0.36) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL29312692 | 0.93 | ALOX5 (0.43) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL22044951 | 0.93 | ALOX5 (0.37) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL29312585 | 0.91 | ALOX5 (0.40) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL29312618 | 0.91 | ALOX5 (0.40) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL19607008 | 0.89 | ALOX5 (0.41) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL19607130 | 0.89 | ALOX5 (0.41) | ALOX5TNKSTNKS2ESR2PRKDC | |
| SCHEMBL23867457 | 0.89 | ALOX5 (0.35) | ALOX5TNKSAHR | |
| SCHEMBL29312701 | 0.89 | ALOX5 (0.35) | ALOX5TNKSAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
| US-20200172524-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, LEF1 | ALOX5 1372/4885TNKS 3909/4885TNKS2 4130/4885 |
| US-20200172524-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | ALOX5 1372/4885TNKS 3909/4885TNKS2 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.